Moutih Rafei
Chief Tech/Sci/R&D Officer at DEFENCE THERAPEUTICS INC.
Net worth: 87 500 $ as of 2024-03-30
Profile
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-01 | 70,000 ( 0.16% ) | 87 500 $ | 2024-03-30 |
Moutih Rafei active positions
| Companies | Position | Start |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2020-10-08 |
| University of Montréal | Corporate Officer/Principal | - |
Former positions of Moutih Rafei
| Companies | Position | End |
|---|---|---|
IntelliStem Technologies, Inc.
 IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Founder | 2023-07-31 |
Training of Moutih Rafei
| McGill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
| Defence Therapeutics Inc |
- Stock Market
- Insiders
- Moutih Rafei
